Previous 10 | Next 10 |
- Non-dilutive financing facility, plus $312M existing cash on hand as of June 30, 2022, gives atai access to up to $487M to continue developing next generation mental health treatments - Flexible draw availability provides optionality to optimize liquidity and capital struc...
COMPASS Pathways is developing a psychedelic drug to treat many mental illnesses. The drug appears to be safe and effective for a wide range of mental health problems. If the drug gets authorized and approved, it will be the only available pharmacological treatment for millions an...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study whether the active component of “magic...
NEW YORK and BERLIN, Aug. 01, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, plans to announce its second quarter 2022 financial results and busi...
Atai Life Sciences (NASDAQ: ATAI) , a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, was featured in a recent analysis report that discusses... To read the full report and view the infographic, please visit https://ibn.fm/SHjWL ...
On July 13, 2022, two amendments passed in the House of Representatives that would provide psychedelic drug treatment to veterans and active duty service members. A documentary based on Michael Pollan's 2018 book, "How to Change Your Mind," is one of Netflix's most-watched shows. ...
Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam war and is still the preferred anesthetic in battlefield situations...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips State and federal governments have played a larger role when it comes to approving illegal substances. Most notably, cannabis stocks have been in focus over the last few years, as various government bodies have given mariju...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: rhendrikdwenz via Shutterstock So far, 2022 has been a rocky year for Cathie Wood’s exchange-traded funds (ETFs). Her flagship fund, the ARK Innovation ETF (NYSEARCA: ARKK ) is down more than 50% ye...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cathie Wood’s flagship fund, the ARK Innovation (NYSEARCA: ARKK ) exchange-traded fund (ETF), has lost over 50% since the year began. However, investors still seem to be confident in ARK Invest’s activ...
News, Short Squeeze, Breakout and More Instantly...
ATAI Life Sciences N.V. Company Name:
ATAI Stock Symbol:
NASDAQ Market:
ATAI Life Sciences N.V. Website:
Alcohol use disorder is a disorder characterized by an inability to stop or control one’s drinking despite adverse health, occupational or social consequences. Conventional treatments include medication, behavioral therapy, and support groups. Even with these treatments, however, many ind...
Psychedelics such as DMT, LSD and psilocybin have demonstrated promise in the treatment of affective symptoms of a range of disorders. These drugs work by inducing an altered state of consciousness , which includes intensified perceptions and emotions, which have been associated with therapeutic...